Variant report
Variant | nsv820170 |
---|---|
Chromosome Location | chr11:107782011-107788385 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs5921603 | chr11:107783611-107783612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs577221455 | chr11:107783614-107783615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79783012 | chr11:107783629-107783630 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs28473153 | chr11:107783638-107783639 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs7128167 | chr11:107783639-107783640 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
6 | rs75722091 | chr11:107783640-107783641 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77443894 | chr11:107783643-107783644 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs4397471 | chr11:107783651-107783652 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs554460545 | chr11:107783656-107783657 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs138146098 | chr11:107783662-107783663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs7329565 | chr11:107783676-107783677 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs62080693 | chr11:107783687-107783688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs35448943 | chr11:107783688-107783689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs543182645 | chr11:107783697-107783698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs561498219 | chr11:107783700-107783701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs77754139 | chr11:107783701-107783702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs537297129 | chr11:107783703-107783704 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs375094846 | chr11:107783720-107783721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs11089467 | chr11:107783721-107783722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs28450489 | chr11:107783722-107783723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35509055 | chr11:107783726-107783727 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs74175042 | chr11:107783728-107783729 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs113759561 | chr11:107783730-107783731 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs74175043 | chr11:107783735-107783736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs75043480 | chr11:107783737-107783738 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs543938714 | chr11:107783741-107783742 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs76648920 | chr11:107783743-107783744 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs74175044 | chr11:107783749-107783750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs76033799 | chr11:107783758-107783759 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs74175046 | chr11:107783768-107783769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs74175047 | chr11:107783782-107783783 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs71325759 | chr11:107783788-107783789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs71325760 | chr11:107783790-107783791 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs61906915 | chr11:107783791-107783792 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs74175048 | chr11:107783795-107783796 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs74175049 | chr11:107783801-107783802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs76337983 | chr11:107783804-107783805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144307520 | chr11:107783815-107783816 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs74175050 | chr11:107783819-107783820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs565241976 | chr11:107783832-107783833 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs532557548 | chr11:107783848-107783849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs74175051 | chr11:107783856-107783857 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs74175052 | chr11:107783865-107783866 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs551357905 | chr11:107783868-107783869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs74175053 | chr11:107783880-107783881 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs71325761 | chr11:107783891-107783892 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs71450008 | chr11:107783908-107783909 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs74175054 | chr11:107783910-107783911 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs74175055 | chr11:107783943-107783944 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs566737840 | chr11:107783963-107783964 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 17603634 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Breast cancer | 21364760 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Mental retardation | 19966786 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Intracranial aneurysm | 16715129 | CNVD |
Ovine squamous-cell carcinoma | 17599052 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Chronic lymphocytic leukemia | 17805327 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Breast cancer | 16397240 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Malignant melanoma | 17260012 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Prostate cancer | 16573809 | CNVD |
Prostate cancer | 18632612 | CNVD |
Obesity | 19966786 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Cancer | 20164920 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Attention deficit hyperactivity disorder | 19546859 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:107783600-107784400 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr11:107784000-107785000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr11:107785000-107786400 | Enhancers | Placenta | Placenta |
4 | chr11:107786400-107787600 | Weak transcription | Placenta | Placenta |
5 | chr11:107787200-107787800 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr11:107787200-107787800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
7 | chr11:107787400-107787800 | Bivalent Enhancer | Primary T cells fromperipheralblood | blood |
8 | chr11:107787600-107787800 | Enhancers | Primary B cells from peripheral blood | blood |
9 | chr11:107787600-107787800 | Bivalent Enhancer | Brain Angular Gyrus | brain |
10 | chr11:107787600-107787800 | Enhancers | Placenta | Placenta |